Abstract For some diseases, successful vaccines have been developed using a nonpathogenic counterpart of the causative microorganism of choice. The nonpathogenicity of the rodent Plasmodium berghei (Pb)
A program to vaccinate young children in high-risk areas for malaria begins today (April 23) in Malawi, and will soon roll out in Ghana and
Plasmodium falciparum resistance to artemisinin-based combination therapies (ACTs) started to crop up around 2007. Infections, especially in the Greater Mekong area of Southeast Asia, seemingly
The malaria vaccine doesn’t provide lasting protection against the mosquito-borne disease, according to a study published yesterday (June 29) in NEJM: it delays infections by
Researchers have identified a gene that kickstarts the male-specific genetic program in the African malaria mosquito Anopheles gambiae. When expressed in genetically female mosquito embryos,
Created by ePubSystems. Contact Us for similar site for your university or institute.